Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ACTUATE THERAPEUTICS INC.”

7 pharma patents match "ACTUATE THERAPEUTICS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "ACTUATE THERAPEUTICS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “ACTUATE THERAPEUTICS INC.” · 30,257 patents in full index Clear search

  1. US 12145943

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  2. US 12116374

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  3. US 12083098

    Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors

    ACTUATE THERAPEUTICS INC. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  4. US 11980607

    Methods of treating malignant lymphoproliferative disorders

    ACTUATE THERAPEUTICS INC. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  5. US 11510904

    Methods of treating malignant lymphoproliferative disorders

    ACTUATE THERAPEUTICS INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  6. US 11407759

    Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  7. US 11136334

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted